
Professor Milton Packer
Baylor University Medical Center, Dallas (United States of America)
Membership:
FESC Member
HFA Member
Follow
Biography
Milton Packer is the Distinguished Scholar in Cardiovascular Science at Baylor University Medical Center at Dallas and Visiting Professor at Imperial College, London. He is an internationally recognized clinical investigator who has made many seminal contributions to the field of heart failure, both in understanding its mechanisms and defining its rational management. Spanning nearly 50 years, his work with ACE inhibitors, beta-blockers, angiotensin neprilysin and SGLT2 inhibitors established the cornerstones of the modern treatments for heart failure. He proposed the neurohormonal hypothesis of heart failure in 1992; he has led 20 large-scale international trials in heart failure; and he has received many international awards in recognition of his achievements. His popular and iconoclastic column on MedPage Today received the Jesse H. Neal Award, the equivalent of the Pulitzer Prize for business journalism. He has received both the Gold Medal and the Silver Medal from the ESC.
Contributor content
Session
Great Debate: how to manage patients with heart failure and atrial fibrillation
27 August 2023
Session
Heart failure specifics in chronic kidney disease
29 June 2021
Session
Recent clinical trials and insights from preclinical studies
29 June 2021
Session
The Lancet - ESC symposium on heart failure
27 August 2018
Session
Current controversies in clinical trial design
26 August 2018
Session
Planning a new trial – What endpoints?
28 May 2018
Session
Late-Breaking Science in Heart Failure
28 August 2017
Session
The Heart failure Summit
28 August 2017
Session
Renal dysfunction and iron deficiency: facts, myths, and solutions
26 August 2017

